NCT02101944 2024-05-17
Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
National Cancer Institute (NCI)
Phase 1 Completed
Clinical Trials
7 trialsNCT02948283 2021-02-12
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
City of Hope Medical Center
Phase 1 Completed
NCT01340976 2018-10-03
A Phase 1 Study of LY2787106 in Cancer and Anemia
Eli Lilly and Company
Phase 1 Completed
NCT00735930 2015-04-02
Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00294203 2014-04-15
Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer
University of Florida
Phase 1 Completed
NCT00097747 2012-12-21
Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers
Affymax
Phase 1 Completed
NCT00001533 2006-07-17
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine
National Institutes of Health Clinical Center (CC)
Phase 1 Completed